# A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers

> **NCT01877889** · PHASE1 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Canagliflozin
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT01877889
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01877889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01877889, "A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01877889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*